AzTrials
AzTrials

Necrotizing EnterocolitisNCT07526636

Pattern And Outcome Of Neonatal Gastrointestinal Emergencies In Assiut University Children Hospital

An observational study of Necrotizing Enterocolitis and Intestinal Atresia, run by Assiut University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Official record
Search all trials

Trial summary

This prospective observational study aims to evaluate the pattern, clinical presentation, complications, and short-term outcomes of neonates admitted with gastrointestinal emergencies to the NICU at Assiut University Children Hospital. Read more about this study

Who is it for?
Ages 1 minute to 28 days
How many people
120 participants
Where
No sites listed yet
Study dates
1 May 2026to 1 Apr 2027
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 1 minute to 28 days
  • All sexes
  • Child

Study population: Neonates admitted to the NICU at Assiut University Children Hospital with gastrointestinal emergencies, including both term and preterm infants from 28 weeks gestational age, observed from admission through discharge.

Who may be able to join

  • Neonates aged 0-28 days (corrected age if preterm)
  • Admitted to the NICU with a clinical diagnosis of a gastrointestinal emergency requiring urgent intervention
  • Written informed consent obtained from parent(s) or legal guardian(s)

Who cannot join

  • Other gastrointestinal problems not requiring urgent intervention

About this study

Official title: Pattern And Outcome Of Neonatal Gastrointestinal Emergencies In Assiut University Children Hospital: A Prospective Observational Cohort Study

This prospective observational study aims to evaluate the pattern, clinical presentation, complications, and short-term outcomes of neonates admitted with gastrointestinal emergencies to the NICU at Assiut University Children Hospital. Data will be collected from admission through discharge, including demographic, antenatal, natal, clinical, nutritional, laboratory, and radiological information, to identify the most common emergencies and factors associated with adverse outcomes.

Read the detailed description

This prospective observational cohort study will be conducted at the Neonatal Intensive Care Unit (NICU) of Assiut University Children Hospital. The study aims to evaluate the pattern, clinical presentation, complications, and short-term outcomes of neonatal gastrointestinal emergencies.

Eligible neonates will be enrolled consecutively from admission until discharge. Both term and preterm neonates will be included. Data will be systematically collected on demographic characteristics, antenatal and natal history, clinical presentation, feeding practices, laboratory investigations, and radiological findings.

Management approaches, including medical and surgical interventions, will be documented. Patients will be followed throughout their hospital stay to assess outcomes, including recovery, complications, need for surgical intervention, and mortality.

The study also aims to identify the most common types of gastrointestinal emergencies and determine the clinical and demographic factors associated with adverse outcomes among affected neonates.

Keywords
Neonate, NICU, Gastrointestinal emergency, Intestinal obstruction
Medical subject headings
Enterocolitis, Necrotizing, Intestinal Atresia, Volvulus Of Midgut, Hirschsprung Disease, Intestinal Obstruction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Prevalence of the most common gastrointestinal emergencies among neonates admitted to the NICU

    The prevalence of each type of neonatal gastrointestinal emergency will be calculated as the proportion of cases among all enrolled neonates admitted to the NICU during the study period. Diagnoses will be based on clinical, laboratory, and radiological findings.

    Measured: Up to 28 days (hospital stay)

Secondary outcomes (3)
  1. Mortality Rate

    Proportion of neonates who die during hospitalization

    Measured: Up to 28 days (hospital stay

  2. Length of Hospital Stay

    Duration of hospitalization in days from NICU admission until discharge or death

    Measured: From admission to discharge, up to 28 days

  3. Requirement for surgical intervention

    The proportion of neonates requiring surgical management among the enrolled cases.

    Measured: During hospitalization, up to 28 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Apr 2026
  2. Study start1 May 2026 (estimated)
  3. Primary completion1 Apr 2027 (estimated)
  4. Study completion1 Apr 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07526636
Sponsor's protocol ID
AUCH-NGIT-2026
Status last verified
Apr 2026
First submitted
3 Apr 2026
Last updated
13 Apr 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Necrotizing Enterocolitis and Intestinal Atresia, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Prevalence of the most common gastrointestinal emergencies among neonates admitted to the NICU (time frame: Up to 28 days (hospital stay)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026; AzTrials last refreshed its copy on 26 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in